Pivagabine

Pivagabine is an antiepileptic drug investigated for the treatment of epilepsy. It acts by inhibiting the breakdown of gamma-aminobutyric acid (GABA), thereby increasing inhibitory neurotransmission in the brain to help control seizures. Its therapeutic use is listed as antidepressants. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include N-trimethylacetyl GABA and Pivagabina. Its PubChem CID is 68888.

CAS No 69542-93-4
Molecular Formula C9H17NO3
Molecular Weight 187.24 g/mol
Synonyms 4-(2,2-dimethylpropanoylamino)butanoic acid

Frequently Asked Questions